Results 241 to 250 of about 308,418 (340)

p53 mutations do not predict response to paclitaxel in metastatic nonsmall cell lung carcinoma [PDF]

, 2000
Thomas C. King, Wallace Akerley, Alice C. Fan, Todd T. Moore, Shamlal Mangray, Mei‐Hsiu Chen, Howard Safran   +6 more
openalex   +1 more source

Mechanism and role of regulated cell death in tumor immunity and immunotherapy

Cancer Communications, EarlyView.
Abstract Cancer immune checkpoint inhibitors (ICIs) have brought breakthroughs, but only about one‐third of cancer patients benefit from ICIs. In recent years, targeting non‐apoptotic regulated cell death (RCD) subtypes, such as ferroptosis, necroptosis, autophagy, cuproptosis, and pyroptosis, has emerged as a novel strategy in cancer therapy due to ...
Jingwen Hu, Yan Li, Bingjie Lian, Yitao Mao, Luqing Zhao   +4 more
wiley   +1 more source

Efficacy of albumin-bound paclitaxel versus paclitaxel in esophageal cancer: a systematic review and meta-analysis. [PDF]

Front Oncol
Song J, Xiong Y, Liu H, Zhang W, Tan Z, Liu N.   +5 more
europepmc   +1 more source

Dose-finding study of paclitaxel and cyclophosphamide in advanced breast cancer

, 1997
Olivia Pagani, Cristiana Sessa, Giovanni Martinelli, T. Cerny, J. de Jong, Aron Goldhirsch, Matteo Zimatore, Franco Cavalli   +7 more
openalex   +1 more source

Clinical experience with lapatinib in patients with ErbB2-overexpressing metastatic breast cancer [PDF]

, 2008
Blackwell KL, Burris, Christianson TA, Clayton AJ, Di Leo A, Lin NU, Michael Untch, Nadia Harbeck, Rusnak DW, Schwartz G, Sibylle Loibl, Stemmler J, Storniolo A, Volker Heinemann   +13 more
core   +3 more sources

Breaking barriers: the cGAS‐STING pathway as a novel frontier in cancer immunotherapy

Cancer Communications, EarlyView.
Abstract Since its discovery, the cyclic GMP‐AMP synthase (cGAS)‐stimulator of the interferon gene (STING) signaling pathway has been considered a pivotal component of innate immunity and a promising target for cancer immunotherapy. Beyond its canonical role in pathogen defense, accumulating evidence has demonstrated that the cGAS‐STING pathway ...
Yuheng Yan, Ximin Tan, Bin Song, Ming Yi, Qian Chu, Kongming Wu   +5 more
wiley   +1 more source

Substitution of ifosfamide for cyclophosphamide in the TI-CE regimen: pharmacology and dose justification in a patient with refractory metastatic germ-cell tumor post-nephrectomy-A case report. [PDF]

Cancer Chemother Pharmacol
Hulskotte LMG, de Jong LAW, Huitema ADR, Sijm J, Desar I, Smits M, van Erp NP.   +6 more
europepmc   +1 more source

Design, Synthesis, and Molecular Docking of Triazole‐Coumarin Hybrids as Potent Breast Cancer Inhibitors Targeting Cell Cycle and Apoptosis

Chemistry &Biodiversity, EarlyView.
Triazole‐coumarin hybrids were synthesized as breast cancer inhibitors. Derivative 5f induced S‐phase arrest and apoptosis in cancer cells, with minimal toxicity to healthy cells, showing promise for anticancer drug development. ABSTRACT Breast cancer continues to pose a significant global health burden, highlighting the urgent need for novel ...
Murat Keser, Emre Menteşe, Suleyman Ilhan, Mustafa Emirik, Harika Atmaca   +4 more
wiley   +1 more source

CHFR expression and sensitivity of breast cancer cells to antimitotic agents in vitro and in the I-SPY trial. [PDF]

NPJ Breast Cancer
Wahner Hendrickson AE, Flatten KS, Weiskittel TM, Venkatachalam A, Strathman AR, Rossman OK, Meng XW, Schneider PA, Peterson KL, Correia C, Anderson OJ, Singh S, Couch FJ, Esserman LJ, Hylton NM, Onishi N, DeMichele AM, Chen J, Li H, Ingle JN, Goetz MP, Kaufmann SH.   +21 more
europepmc   +1 more source

Phase II study of paclitaxel in patients with metastatic breast carcinoma refractory to standard chemotherapy [PDF]

, 2000
Edgardo Rivera, Frankie A. Holmes, Debra Frye, Vicente Valero, Richard L. Theriault, Daniel J. Booser, Ronald S. Walters, Aman U. Buzdar, Kapil Dhingra, Giuseppe Fraschini, Gabriel N. Hortobagyi   +10 more
openalex   +1 more source